With a targeted immunostimulatory mechanism, a necroptotic tumor cell mimicry nanovaccine has proven to increase antitumor immunity, inducing the expansion of natural killer (NK) cells and CD8+ T cell, and multiepitope T cell responses [16]. Here, CD8A is linked to neoplasm.